论文部分内容阅读
他曾为医药事业的发展倾注了大量心血,他奋斗在新药研究开发和科技管理工作的征程中。上世纪90年代中期,李光平由上海市科委委派,担任中方谈判代表负责国家科委推荐的和上海市积极引进的生物医药合资项目的谈判,负责(中日合资)麒麟鲲鹏(中国)生物药业有限公司筹建工作。
He devoted a great deal of effort to the development of the pharmaceutical industry and he worked hard on the journey of research, development and technology management of new drugs. In the mid-90s of the last century, Li Guangping was appointed by the Shanghai Municipal Science and Technology Commission as the negotiator for the Chinese side in charge of negotiations with the State Science and Technology Commission on the biomedical joint venture project actively introduced by Shanghai Municipality and was responsible for the Sino-Japanese joint venture Kirin Kunpeng (China) Pharmaceutical Co., Ltd. preparatory work.